Kidney transplant drug study halted early: what happened?

NCT ID NCT04294459

First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 24 times

Summary

This study tested a drug called isatuximab in 23 people waiting for a kidney transplant. The goal was to see if it could safely lower certain immune system antibodies that make it hard to find a matching donor. The study was stopped early, so the full results are not available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE SYSTEM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number :7240001

    L'Hospitalet de Llobregat, Catalunya [Cataluña], 08907, Spain

  • Investigational Site Number :7240002

    Barcelona, Barcelona [Barcelona], 08035, Spain

  • Investigational Site Number :8400001

    Rochester, Minnesota, 55905, United States

  • Investigational Site Number :8400002

    New York, New York, 10016, United States

  • Investigational Site Number :8400003

    San Francisco, California, 94143, United States

  • Investigational Site Number :8400004

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.